# INVE Technologies, Inc.: overview INVE · Nasdaq · CIK 1036044 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/inve.md) · [Financials](/companies/inve/financials.md) · [Filings](/companies/inve/filings.md) · [Insiders](/companies/inve/insiders.md) Latest reported revenue: [$5.7m](/filings/0001193125-26-349265.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-349265). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [6,532](/filings/0001193125-25-274412.md) | [6,697 d](/filings/0001193125-26-126351.md) | [5,269](/filings/0001193125-26-223705.md) | [5,040](/filings/0001193125-26-349265.md) | [5,009](/filings/0001193125-25-274412.md) | [6,166 d](/filings/0001193125-26-126351.md) | [7,413](/filings/0001193125-26-223705.md) | [5,681](/filings/0001193125-26-349265.md) | | Gross margin | % | [3.6%](/filings/0001193125-25-274412.md) | [(14.9%) d](/filings/0001193125-26-126351.md) | [2.5%](/filings/0001193125-26-223705.md) | [(9.4%)](/filings/0001193125-26-349265.md) | [10.7%](/filings/0001193125-25-274412.md) | [18.1% d](/filings/0001193125-26-126351.md) | [17.4%](/filings/0001193125-26-223705.md) | [16.1%](/filings/0001193125-26-349265.md) | | Operating margin | % | [(146.2%)](/filings/0001193125-25-274412.md) | [(98.9%) d](/filings/0001193125-26-126351.md) | [(103.8%)](/filings/0001193125-26-223705.md) | [(126.7%)](/filings/0001193125-26-349265.md) | [(111.4%)](/filings/0001193125-25-274412.md) | [(76.4%) d](/filings/0001193125-26-126351.md) | [(56.7%)](/filings/0001193125-26-223705.md) | [(97.0%)](/filings/0001193125-26-349265.md) | | Net margin | % | [1315.8%](/filings/0001193125-25-274412.md) | [(5.3%) d](/filings/0001193125-26-126351.md) | [(90.9%)](/filings/0001193125-26-223705.md) | [(119.9%)](/filings/0001193125-26-349265.md) | [(68.9%)](/filings/0001193125-25-274412.md) | [(60.3%) d](/filings/0001193125-26-126351.md) | [(46.5%)](/filings/0001193125-26-223705.md) | [(81.9%)](/filings/0001193125-26-349265.md) | | Diluted EPS | $ per share | [3.62](/filings/0001193125-25-274412.md) | not reported | [(0.21)](/filings/0001193125-26-223705.md) | [(0.26)](/filings/0001193125-26-349265.md) | [(0.15)](/filings/0001193125-25-274412.md) | not reported | [(0.15)](/filings/0001193125-26-223705.md) | [(0.20)](/filings/0001193125-26-349265.md) | | Free cash flow | $k | [(7,722) d](/filings/0001193125-25-274412.md) | [(6,543) d](/filings/0001193125-26-126351.md) | [(3,581)](/filings/0001193125-26-223705.md) | [(3,820) d](/filings/0001193125-26-349265.md) | [(3,233) d](/filings/0001193125-25-274412.md) | [2,823 d](/filings/0001193125-26-126351.md) | [(3,717)](/filings/0001193125-26-223705.md) | [(5,067) d](/filings/0001193125-26-349265.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [104](/filings/0000950170-24-031816.md) | [113](/filings/0000950170-24-031816.md) | [43.4](/filings/0000950170-25-040387.md) | [26.6](/filings/0001193125-26-126351.md) | [21.5](/filings/0001193125-26-126351.md) | | Gross margin | % | [35.7%](/filings/0000950170-24-031816.md) | [36.3%](/filings/0000950170-24-031816.md) | [13.8%](/filings/0000950170-25-040387.md) | [1.3%](/filings/0001193125-26-126351.md) | [6.1%](/filings/0001193125-26-126351.md) | | Operating margin | % | [(1.3%)](/filings/0000950170-24-031816.md) | [(0.3%)](/filings/0000950170-24-031816.md) | [(31.1%)](/filings/0000950170-25-040387.md) | [(105.0%)](/filings/0001193125-26-126351.md) | [(103.1%)](/filings/0001193125-26-126351.md) | | Net margin | % | [1561159.9%](/filings/0001193125-24-122187.md) | [(347163.8%)](/filings/0001193125-24-122187.md) | [(12.6%)](/filings/0000950170-25-040387.md) | [281.0%](/filings/0001193125-26-126351.md) | [(83.8%)](/filings/0001193125-26-126351.md) | | Diluted EPS | $ per share | [0.02](/filings/0000950170-24-031816.md) | [(0.07)](/filings/0000950170-24-031816.md) | [(0.29)](/filings/0000950170-25-040387.md) | [3.14](/filings/0001193125-26-126351.md) | [(0.79)](/filings/0001193125-26-126351.md) | | Free cash flow | $m | [(0.9)](/filings/0000950170-24-031816.md) | [(11.7)](/filings/0000950170-24-031816.md) | [(3.1)](/filings/0000950170-25-040387.md) | [(16.9)](/filings/0001193125-26-126351.md) | [(7.8)](/filings/0001193125-26-126351.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/inve/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Bleichroeder LP](/funds/1781002.md) | 2026-06-30 | $7.3m | 2,884,495 | | Unchanged | | [AIGH Capital Management LLC](/funds/1835943.md) | 2026-06-30 | $3.7m | 1,449,121 | | Added +1,039,935 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.3m | 915,864 | | Reduced −135,995 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $1.5m | 587,212 | | Added +210,482 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.3m | 516,382 | | Added +254,598 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $1.3m | 501,236 | | Reduced −675,304 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $1.2m | 484,438 | | Reduced −252,170 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $839.2k | 333,004 | | Added +17,257 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $625.7k | 248,229 | | Added +6,379 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $570.3k | 226,257 | | Added +18,493 | ## Recent filings [All 1,152 filings](/companies/inve/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 07:14 ET | [8-K](/filings/0001213900-26-114053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-114053 | | 2026-10-23 | 18:20 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002848.md) | Ownership report, active investor, amended | 0000921895-26-002848 | | 2026-10-21 | 07:20 ET | [8-K](/filings/0001213900-26-111181.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111181 | | 2026-09-18 | 16:05 ET | [8-K](/filings/0001193125-26-395516.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-395516 | | 2026-09-16 | 16:01 ET | [8-K](/filings/0001193125-26-393037.md) | 2.01 Completion of an acquisition or disposition; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-393037 | | 2026-08-25 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001420506-26-001958.md) | Ownership report, active investor, amended | 0001420506-26-001958 | | 2026-08-24 | 16:36 ET | [8-K](/filings/0001193125-26-363682.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363682 | | 2026-08-13 | 16:20 ET | [10-Q](/filings/0001193125-26-349265.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349265 | | 2026-08-12 | 16:19 ET | [8-K](/filings/0001193125-26-346913.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346913 | | 2026-08-05 | 17:02 ET | [8-K](/filings/0001193125-26-335440.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-335440 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-126351.md), filed Mar 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1036044 - Tickers: INVE - Exchange: Nasdaq - SIC code: 3577 Computer Peripheral Equipment, NEC - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 07:17 ET. No prices; not investment advice.